Who Owns Terveystalo Company?

Terveystalo Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Owns Terveystalo?

Understanding a company's ownership is key to grasping its future. Knowing "Who owns Terveystalo?" unveils critical insights into its strategic direction and potential for growth. From its IPO to the present, the evolution of Terveystalo's ownership structure has been a dynamic journey.

This analysis explores the fascinating shifts in Terveystalo's ownership, from its initial private equity backing to its current status as a publicly traded entity. We'll examine the major Terveystalo SWOT Analysis, including the influence of Terveystalo shareholders and Terveystalo investors, providing a clear picture of who controls this prominent Finnish healthcare provider. Discover the Terveystalo company history and ownership details, and learn about the Terveystalo management.

The story of the Terveystalo company began in 2001 with the merger of Medipa Oy and Vaajakoski Medical Center Oy. This marked the start of a journey to build a nationwide medical clinic network across Finland. Initially, the company launched with four clinics and a team of about 60 healthcare professionals.

While the exact details of the founders and their initial shareholdings are not readily available, the early years were marked by significant growth. Between 2002 and 2007, the company engaged in over a hundred corporate and business deals, shaping its expansion and market presence. These early transactions were crucial in establishing the foundation for its future growth.

Private equity played a role in the early ownership of Terveystalo. The company's listing on Nasdaq Helsinki in early 2007 was a key milestone. A significant event was the acquisition of Medivire Työterveyspalvelut Oyj in June 2007 for 127 million euros. This acquisition solidified Terveystalo's position as the largest private healthcare company in Finland.

Key Early Developments

The early years of Terveystalo saw substantial growth and strategic acquisitions. The company's focus was on expanding its clinic network and solidifying its market position. Key milestones included the initial public offering and significant acquisitions.

• 2001: Merger of Medipa Oy and Vaajakoski Medical Center Oy.
• 2002-2007: Over 100 corporate and business deals.
• Early 2007: Initial listing on Nasdaq Helsinki.
• June 2007: Acquisition of Medivire Työterveyspalvelut Oyj for 127 million euros.

Terveystalo SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership of the Terveystalo company has seen significant shifts, particularly influenced by private equity investments and its public listings. Initially listed in early 2007, the company faced challenges during the global financial crisis. In 2009, Bridgepoint Group, through its subsidiary Star Healthcare, acquired Terveystalo Healthcare Plc and delisted it from the Helsinki Stock Exchange. Star Healthcare held approximately 97.9% of the company's stock by early summer 2009, completing the acquisition by August of that year.

During Bridgepoint's ownership, Terveystalo focused on centralizing group services and standardizing processes. In September 2013, Bridgepoint sold Terveystalo to EQT VI, a Swedish private equity firm. Under EQT's ownership, Terveystalo invested in digital services, consumer branding, and expanding its nationwide network. The company was re-listed on the Helsinki Stock Exchange on October 13, 2017, with an initial market capitalization of approximately EUR 1,250 million.

As of December 2024, institutional investors held a significant majority, owning over 50% of the company, with 64% ownership. The general public held an 18% stake, and private companies owned 17%. Keskinäinen työeläkevakuutusyhtiö Varma is currently the largest shareholder, holding 17% of outstanding shares. Other notable institutional shareholders include Rettig Group Oy Ab, Pohjola Vakuutus Oy, and Hartwall Capital. OP Financial Group's total holding in Terveystalo Plc was 13.91%, equating to 17,675,975 shares as of February 18, 2025. For more insights into the company's journey, consider reading Brief History of Terveystalo.

Key Takeaways on Terveystalo Ownership

Terveystalo's ownership structure has evolved from public to private and back to public, with significant involvement from private equity firms.

• Institutional investors hold the majority of shares.
• Key shareholders include Keskinäinen työeläkevakuutusyhtiö Varma, Rettig Group Oy Ab, and OP Financial Group.
• The company's history includes periods of delisting and re-listing on the Helsinki Stock Exchange.
• Understanding the ownership structure is crucial for investors and stakeholders.

Terveystalo PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Annual General Meeting (AGM) is the highest decision-making body for the Terveystalo company, handling crucial matters like approving financial statements, deciding on dividends, electing board members, and determining their compensation. Each share of Terveystalo grants the holder one vote. Understanding the Terveystalo ownership structure is key for Terveystalo investors and anyone interested in the company's direction.

As of April 8, 2025, the Board of Directors of Terveystalo consists of seven members. Kari Kauniskangas chairs the board, with Matts Rosenberg as Vice Chairman. The re-elected members, serving until the 2026 Annual General Meeting, include Kari Kauniskangas, Sofia Hasselberg, Ari Lehtoranta, Carola Lemne, Kristian Pullola, Matts Rosenberg, and Teija Sarajärvi. The Shareholders' Nomination Board, which proposes board candidates and remuneration, includes representatives from the four largest shareholders and the Chairman of the Board. Knowing who controls Terveystalo is important for understanding its strategic direction.

The Nomination Board, as of September 2, 2024, includes Risto Murto (Varma Mutual Pension Insurance Company), Tomas von Rettig (Rettig Group AB), Timo Ritakallio (Pohjola Insurance Ltd and OP Life Assurance Company Ltd), and Kari Kauniskangas (Chairman of the Board of Directors of Terveystalo Plc). While most board members are considered independent, Matts Rosenberg is not, due to his role as CEO of Rettig Group. The 2025 AGM approved annual remuneration of EUR 91,800 for the Chairman, EUR 54,000 for the Vice-Chairman, EUR 43,100 for members, and EUR 54,000 for the Chairman of the Audit Committee. For more information on the competitive landscape, you can read about the Competitors Landscape of Terveystalo.

Key Takeaways on Terveystalo Ownership

The Board of Directors plays a vital role in the strategic direction of Terveystalo. Understanding the composition of the board and the voting power of shareholders is crucial for anyone interested in Terveystalo's ownership structure.

• The AGM is the primary decision-making body.
• Each share equals one vote.
• The Board consists of seven members as of April 2025.
• The Nomination Board proposes board candidates.

Terveystalo Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

In the past few years, the Terveystalo company has seen shifts in its ownership landscape. Recent reports, including the Annual Report 2024 published on March 14, 2025, provide key insights into these changes. For instance, there was a notification on February 19, 2025, indicating that OP Life Assurance Company Ltd's stake in Terveystalo shares and votes decreased below 5%, although OP Financial Group's total holding remained at 13.91%. These developments are crucial for understanding the current Terveystalo ownership structure and the influence of major Terveystalo shareholders.

The company also focuses on aligning the interests of Terveystalo management with shareholder value. The Board of Directors approved new performance periods for long-term share-based incentive plans for key personnel, covering 2024–2026 and 2025–2027. These plans include share ownership requirements for Executive Team members, who are expected to retain at least 50% of net shares received until their shareholding equals their annual gross base salary. These initiatives aim to ensure that Terveystalo investors and management are working towards the same goals.

Terveystalo's commitment to growth is evident through its updated medium-term financial targets. The company aims for earnings per share (EPS) to grow by an average of 10% per annum, with faster growth expected in 2025. The company also targets a moderate leverage ratio, with net debt to EBITDA not exceeding 2.5x, although this may temporarily be surpassed during acquisitions. For additional insights into the company's strategic approach, explore the Marketing Strategy of Terveystalo.

Key Development

OP Life Assurance Company Ltd's holding fell below 5% in February 2025.

Financial Target

EPS growth of 10% per annum, with faster growth expected in 2025.

Dividend Policy

Distribute at least 80% of net profit as dividends.

Share Incentive Plans

New plans for key personnel covering 2024–2026 and 2025–2027.

Terveystalo Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs